Latest Australia News

Helix Resources has closed a $2 million placement to fund exploration across its Pilbara gold projects, but the issue still needs shareholder approval at an extraordinary meeting on 21 October. The deal adds 50 million shares and 50 million attaching options to the company’s capital structure.

Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.

Actinogen Medical says its pivotal XanaMIA Alzheimer’s trial remains on course for topline results in November after the final patient visit was completed. The company also reported $15.9 million in cash, a further $5.3 million from option funding and a projected runway into late 2027 or 2028, assuming future trials are substantially partner-funded.

Firebird Metals has produced 99.999% ultra-high-purity manganese sulphate at its Hunan pilot plant and started processing ore from its Western Australian Oakover project. The next test is whether the result can be independently replicated with Australian feedstock before the Perth demonstration plant begins commissioning in 2027.

Cobalt Blue has signed a non-binding term sheet with Swiss trader STG Metals for cobalt metal from its proposed Kwinana refinery. The proposed deal covers up to 1,000 tonnes a year, but construction, product qualification and a definitive agreement remain outstanding.

Mount Ridley has lodged a second provisional patent application for an adapted Selectro chemistry targeting industrial metal feedstocks, following first-pass bauxite recoveries of 92% aluminium and 97% iron. Gallium results are still pending, and the process has not yet been optimised for bauxite.

Boresight Ltd (ASX: BST) used its first quarter after listing to build inventory, expand its US manufacturing footprint and prepare for a larger military order, despite unaudited revenue of about A$829,000. Cash stood at A$5.39 million with no debt after operating outflows of A$2.28 million.

Nyrada has moved its PROTECT-MI heart-attack trial into active recruitment, with four hospitals open and three patients dosed. The biotech also reported supportive US FDA feedback, encouraging preclinical oncology data and AU$13.72 million in cash after a AU$12 million placement.

Cleanaway has signed a binding scheme implementation deed for EQT Infrastructure to acquire the waste services group for approximately $9.3 billion. Shareholders are being offered $3.095 cash per share, subject to approvals and any dividends paid before completion.

Albion Resources has secured $1.8 million from sophisticated and professional investors to expand drilling at its Gidgee Gold Project, after an initial aircore hole returned a high-grade gold intersection. The raise will also support the planned acquisition of additional exploration ground, although further drilling is needed to establish continuity and scale.

Northern Minerals will not hold its delayed 2025 AGM or 2026 AGM on 25 November after ASIC granted more time amid suspected non-compliance with federal share disposal orders. Both meetings must now be held by 31 March 2027, unless Treasury confirms compliance earlier.

Falcon Metals has struck 12 metres at 2.8g/t gold from surface in the first hole at its Olsen Well prospect, including 4 metres at 4.7g/t. The result has confirmed bedrock mineralisation beneath a 5.8-kilometre soil anomaly, but four nearby holes were only weakly anomalous and the geometry remains unresolved.